<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
    <channel>
        <title>Acta Neurologica Scandinavica via MedWorm.com</title>
        <description>MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'Acta Neurologica Scandinavica' source.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=Acta+Neurologica+Scandinavica&t=Acta+Neurologica+Scandinavica&s=Search&f=source]]></link>
        <lastBuildDate>Wed, 08 Feb 2012 20:42:54 +0100</lastBuildDate>
        <item>
            <title>Depressive symptoms in multiple sclerosis</title>
            <link>http://www.medworm.com/index.php?rid=5668635&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01585.x</link>
            <description>(Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5668635</comments>
            <pubDate>Thu, 09 Feb 2012 00:47:07 +0100</pubDate>
            <guid isPermaLink="false">5668635</guid>        </item>
        <item>
            <title>Ocular torsions and the subjective visual vertical with central vestibulo‐ocular system lesions: independence disproved</title>
            <link>http://www.medworm.com/index.php?rid=5668633&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2012.01651.x</link>
            <description>ConclusionsTorsions and deviations are strongly dependent. This result should allow the generation of a more transparent pathophysiological model. From a practical point of view, measurements of deviation appeared more robust than those of torsion. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5668633</comments>
            <pubDate>Thu, 09 Feb 2012 00:45:00 +0100</pubDate>
            <guid isPermaLink="false">5668633</guid>        </item>
        <item>
            <title>Reduced serum uric acid levels in neuromyelitis optica: serum uric acid levels are reduced during relapses in NMO</title>
            <link>http://www.medworm.com/index.php?rid=5668634&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2012.01643.x</link>
            <description>ConclusionUA levels are associated with clinical disease status in patients with NMO. Further investigations are recommended to elucidate the role of UA as a biomarker of disease activity in NMO. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5668634</comments>
            <pubDate>Mon, 06 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5668634</guid>        </item>
        <item>
            <title>Intravenous thrombolysis in ischemic stroke patients with isolated homonymous hemianopia</title>
            <link>http://www.medworm.com/index.php?rid=5649952&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2012.01646.x</link>
            <description>ConclusionsOur experience encourages application of intravenous thrombolytic treatment (especially when supported with multimodality neuroimaging) in patients with homonymous hemianopia, for which rehabilitation options are limited. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5649952</comments>
            <pubDate>Wed, 01 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5649952</guid>        </item>
        <item>
            <title>Prevalence case‐control study of epilepsy in three Burkina Faso villages</title>
            <link>http://www.medworm.com/index.php?rid=5649954&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01639.x</link>
            <description>DiscussionSeveral factors were associated with prevalent epilepsy, with Ag‐ELISA suggesting the presence of neurocysticercosis. The association between epilepsy and some occupations may reflect differences in local attitudes toward epilepsy and should be further explored. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5649954</comments>
            <pubDate>Tue, 31 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5649954</guid>        </item>
        <item>
            <title>Counting‐backward test for executive function in idiopathic normal pressure hydrocephalus</title>
            <link>http://www.medworm.com/index.php?rid=5649953&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2012.01644.x</link>
            <description>ConclusionThe counting‐backward test is useful for evaluating executive dysfunction in INPH and for differentiating between INPH and AD patients. In particular, the first‐error score may reflect deficits in the response suppression related to executive dysfunction in INPH. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5649953</comments>
            <pubDate>Tue, 31 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5649953</guid>        </item>
        <item>
            <title>Pitfalls in the preoperative diagnosis of bilateral cerebellar infarction</title>
            <link>http://www.medworm.com/index.php?rid=5599254&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01559.x</link>
            <description>(Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5599254</comments>
            <pubDate>Wed, 18 Jan 2012 01:34:01 +0100</pubDate>
            <guid isPermaLink="false">5599254</guid>        </item>
        <item>
            <title>Physical exercise ameliorates deficits induced by traumatic brain injury</title>
            <link>http://www.medworm.com/index.php?rid=5599253&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01638.x</link>
            <description>The extent and depth of traumatic brain injury (TBI) remains a major determining factor together with the type of structural insult and its location, whether mild, moderate or severe, as well as the distribution and magnitude of inflammation and loss of cerebrovascular integrity, and the eventual efficacy of intervention. The influence of exercise intervention in TBI is multiple, ranging from anti‐apoptotic effects to the augmentation of neuroplasticity. Physical exercise diminishes cerebral inflammation by elevating factors and agents involved in immunomodulatory function, and buttresses glial cell, cerebrovascular, and blood–brain barrier intactness. It provides unique non‐pharmacologic intervention that incorporate different physical activity regimes, whether dynamic or static, en...</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5599253</comments>
            <pubDate>Wed, 18 Jan 2012 01:31:43 +0100</pubDate>
            <guid isPermaLink="false">5599253</guid>        </item>
        <item>
            <title>Quantitative T2′ imaging in patients with clinically isolated syndrome</title>
            <link>http://www.medworm.com/index.php?rid=5561929&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01635.x</link>
            <description>ConclusionAs opposed to RRMS, patients with CIS did not show T2′ alterations compared to HC. However, the association between the T2LV and higher T2′ values suggests that T2′ reflects disease evolution. In CIS metabolic changes might be masked by compensatory mechanisms and become overt when disease progresses as has been shown for RRMS patients. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5561929</comments>
            <pubDate>Tue, 03 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5561929</guid>        </item>
        <item>
            <title>Physical activity and multiple sclerosis: new insights regarding inactivity</title>
            <link>http://www.medworm.com/index.php?rid=5561928&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01634.x</link>
            <description>ConclusionsThe primary finding was a moderate reduction in physical activity among those with MS, but the magnitude was substantially smaller than reported in a published meta‐analysis. Importantly, the degree of physical inactivity can likely be overcome through the delivery of behavioral interventions for increasing physical activity and this should translate into meaningful consequences for persons with MS. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5561928</comments>
            <pubDate>Tue, 03 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5561928</guid>        </item>
        <item>
            <title>Anal sphincter electromyography in patients with newly diagnosed idiopathic parkinsonism</title>
            <link>http://www.medworm.com/index.php?rid=5561927&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01633.x</link>
            <description>ConclusionsExternal anal sphincter electromyography examination cannot separate the different parkinsonian subgroups from each other in early course of the diseases. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5561927</comments>
            <pubDate>Tue, 03 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5561927</guid>        </item>
        <item>
            <title>Divergent clinical and neuropathological phenotype in a Gerstmann–Sträussler–Scheinker P102L family</title>
            <link>http://www.medworm.com/index.php?rid=5561926&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01628.x</link>
            <description>ConclusionsThis is the first Scandinavian family carrying the P102L mutation in the PRNP gene. Gerstmann–Sträussler–Scheinker syndrome should be considered in the differential diagnosis when handling with patients with ataxia and/or dementia of unclear aetiology. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5561926</comments>
            <pubDate>Sun, 01 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5561926</guid>        </item>
        <item>
            <title>Isolated leptomeningeal infiltration of a primary CNS B‐cell lymphoma diagnosed by flow cytometry and confirmed by necropsy</title>
            <link>http://www.medworm.com/index.php?rid=5545578&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01630.x</link>
            <description>ConclusionOur case shows that flow cytometry of the CSF in addition to conventional CSF cytology has the potential to accelerate diagnosis of lymphomeningeal infiltration of B‐cell lymphoma. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5545578</comments>
            <pubDate>Wed, 28 Dec 2011 16:57:23 +0100</pubDate>
            <guid isPermaLink="false">5545578</guid>        </item>
        <item>
            <title>Response to manuscript nr: ANE‐L‐03‐11‐149</title>
            <link>http://www.medworm.com/index.php?rid=5526902&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01564.x</link>
            <description>(Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5526902</comments>
            <pubDate>Thu, 22 Dec 2011 13:06:07 +0100</pubDate>
            <guid isPermaLink="false">5526902</guid>        </item>
        <item>
            <title>An association between methylenetetrahydrofolate reductase (C677T) polymorphism and large‐artery ischemic stroke</title>
            <link>http://www.medworm.com/index.php?rid=5526901&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01567.x</link>
            <description>(Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5526901</comments>
            <pubDate>Thu, 22 Dec 2011 13:06:05 +0100</pubDate>
            <guid isPermaLink="false">5526901</guid>        </item>
        <item>
            <title>Algorithm for lamotrigine dose adjustment before, during, and after pregnancy</title>
            <link>http://www.medworm.com/index.php?rid=5488374&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01627.x</link>
            <description>Conclusions –  Seizure deterioration during pregnancy may be prevented or reduced by closely and systematically following our proposed algorithm. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5488374</comments>
            <pubDate>Fri, 09 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5488374</guid>        </item>
        <item>
            <title>Design, methodological issues and participation in a multiple sclerosis case–control study</title>
            <link>http://www.medworm.com/index.php?rid=5506694&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01629.x</link>
            <description>ConclusionsEpidemiological studies play a key role in identifying genetic and environmental factors that are associated with complex diseases like MS. Methodological issues arise in every study, and investigators need to be able to detect, respond to and correct problems in a timely and scientifically valid manner. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5506694</comments>
            <pubDate>Thu, 01 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5506694</guid>        </item>
        <item>
            <title>Central sleep apnea is associated with increased risk of ischemic stroke in the elderly</title>
            <link>http://www.medworm.com/index.php?rid=5488373&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01625.x</link>
            <description>Conclusions –  CSA is the specific respiratory event associated with stroke in the elderly. Additionally, CSA could be a marker of silent brain ischemia, as a sign of disturbed regulation of central respiratory mechanisms, tentatively of ischemic origin. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5488373</comments>
            <pubDate>Thu, 01 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5488373</guid>        </item>
        <item>
            <title>Heart rate variability – a potential early marker of sub‐acute post‐stroke infections</title>
            <link>http://www.medworm.com/index.php?rid=5442919&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01626.x</link>
            <description>Conclusions –  HRV indices are candidates for early markers of developing post‐stroke infections, preceding routine blood samples. Thus, HRV‐based early diagnosis of post‐stroke infection should be investigated in more detail as it may have implications as a novel tool for timely and appropriate treatment. A corresponding continuous HRV‐based risk assessment using the ECG provided by the routine stroke monitoring system would be possible without any additional burden for patients and staff. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5442919</comments>
            <pubDate>Fri, 25 Nov 2011 13:05:43 +0100</pubDate>
            <guid isPermaLink="false">5442919</guid>        </item>
        <item>
            <title>Autosomal dominant Parkinson’s disease in a large German pedigree</title>
            <link>http://www.medworm.com/index.php?rid=5442921&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01621.x</link>
            <description>Conclusions –  The findings in this family further demonstrate genetic heterogeneity in familial autosomal dominant late‐onset PD. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5442921</comments>
            <pubDate>Wed, 23 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5442921</guid>        </item>
        <item>
            <title>Natalizumab vs interferon beta 1a in relapsing‐remitting multiple sclerosis: a head‐to‐head retrospective study</title>
            <link>http://www.medworm.com/index.php?rid=5442920&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01622.x</link>
            <description>Conclusions –  After 12 and 24 months of therapy, natalizumab was more effective than IFN beta 1a SC on both disease activity and disability progression. Prospective head‐to‐head studies would be helpful to further evaluate the differences observed in the MRI outcomes. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5442920</comments>
            <pubDate>Wed, 23 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5442920</guid>        </item>
        <item>
            <title>Long‐lasting TMS motor threshold elevation in mild traumatic brain injury</title>
            <link>http://www.medworm.com/index.php?rid=5432823&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01623.x</link>
            <description>Conclusions –  The results show chronic MT elevation in a sample of subjects with symptomatic or recovered mTBI. This suggests that mTBI may be compensated, although not fully recovered, years after the injury. While the cause for MT elevation cannot be concluded from these preliminary observations, possible explanations include decreased cortical excitability and impaired subcortical conduction. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5432823</comments>
            <pubDate>Tue, 22 Nov 2011 13:01:41 +0100</pubDate>
            <guid isPermaLink="false">5432823</guid>        </item>
        <item>
            <title>Update of the original HDLS kindred: divergent clinical courses</title>
            <link>http://www.medworm.com/index.php?rid=5423674&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01624.x</link>
            <description>Conclusions –  Some HDLS cases were misdiagnosed with unspecified psychiatric diagnoses in affected relatives from the original 1984 publication. However, HDLS is an encephalopathy dominated by a frontal lobe syndrome with an inexorably progressive and fatal course, where the different symptomatology in two recent cases confirmed the existence of acute and chronic variants. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5423674</comments>
            <pubDate>Sat, 19 Nov 2011 13:19:45 +0100</pubDate>
            <guid isPermaLink="false">5423674</guid>        </item>
        <item>
            <title>Cancer risk in people with epilepsy using valproate‐sodium</title>
            <link>http://www.medworm.com/index.php?rid=5401632&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01607.x</link>
            <description>Conclusions –  The lack of an inverse association between valproate use and hazard ratios for all cancers and several individual cancer sites does not lend support for a cancer‐protective role for valproate. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5401632</comments>
            <pubDate>Sun, 13 Nov 2011 12:46:18 +0100</pubDate>
            <guid isPermaLink="false">5401632</guid>        </item>
        <item>
            <title>Autonomic dysfunction in ischemic stroke with carotid stenosis</title>
            <link>http://www.medworm.com/index.php?rid=5401633&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01617.x</link>
            <description>Conclusions –  Cardiovascular autonomic function is impaired in patients with ischemic stroke, but patients with carotid stenosis show more severely impaired parasympathetic and sympathetic functions. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5401633</comments>
            <pubDate>Sat, 12 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5401633</guid>        </item>
        <item>
            <title>Pre‐hospital delays and intravenous thrombolysis in urban and rural areas</title>
            <link>http://www.medworm.com/index.php?rid=5401634&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01616.x</link>
            <description>Conclusions–  Pre‐hospital delays reduced the number of patients eligible for IV thrombolysis in both rural and urban areas. The low proportion of patients treated with IV thrombolysis in rural SUs may be attributed to ineffective in‐hospital procedures. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5401634</comments>
            <pubDate>Fri, 11 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5401634</guid>        </item>
        <item>
            <title>Balancing clinical benefits of vigabatrin with its associated risk of vision loss</title>
            <link>http://www.medworm.com/index.php?rid=5389793&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01603.x</link>
            <description>Pellock JM. Balancing clinical benefits of vigabatrin with its associated risk of vision loss. Acta Neurol Scand: 2011: 124 (Suppl. 192): 83–91. © 2011 John Wiley &amp; Sons A/S.Vigabatrin is an effective and well‐tolerated antiepileptic drug (AED) for the treatment of refractory complex partial seizures (rCPS) and infantile spasms (IS), but its benefits must be evaluated in conjunction with its risk of retinopathy with the development of peripheral visual field defects (pVFDs). Vigabatrin should be considered for rCPS if a patient has failed appropriate trials of other AEDs or is not a suitable candidate for other AEDs, is not an optimal surgical candidate, and continues to experience debilitating effects from seizures. Vigabatrin is indicated as monotherapy for pediatric patient...</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5389793</comments>
            <pubDate>Thu, 10 Nov 2011 14:10:27 +0100</pubDate>
            <guid isPermaLink="false">5389793</guid>        </item>
        <item>
            <title>Non‐vision adverse events with vigabatrin therapy</title>
            <link>http://www.medworm.com/index.php?rid=5389792&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01602.x</link>
            <description>Walker SD, Kälviäinen R. Non‐vision adverse events with vigabatrin therapy. Acta Neurol Scand: 2011: 124 (Suppl. 192): 72–82. © 2011 John Wiley &amp; Sons A/S.Vigabatrin is an effective antiepileptic drug (AED) for the treatment of refractory complex partial seizures (rCPS) and infantile spasms (IS). In clinical trials, vigabatrin was generally well‐tolerated with an adverse event profile similar to that of other AEDs. The most common treatment‐related adverse events were central nervous system effects, including drowsiness, dizziness, headache, and fatigue, with adjunctive vigabatrin in adults with rCPS, and sedation, somnolence, and irritability with vigabatrin monotherapy in infants with IS. Vigabatrin had little effect on cognitive function, mood, or behavior in a batter...</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5389792</comments>
            <pubDate>Thu, 10 Nov 2011 14:10:26 +0100</pubDate>
            <guid isPermaLink="false">5389792</guid>        </item>
        <item>
            <title>Understanding and interpreting vision safety issues with vigabatrin therapy</title>
            <link>http://www.medworm.com/index.php?rid=5389791&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01601.x</link>
            <description>We examined the potential association between pVFDs and epilepsy in vigabatrin‐naïve patients and attempted to identify confounding factors (e.g., concomitant medications, method of vision assessment) to more accurately delineate the prevalence of pVFDs directly associated with vigabatrin. Results of a prospective cohort study as well as several case series and case reports suggest that bilateral visual field constriction is not restricted to patients exposed to vigabatrin but has also been detected, although much less frequently, in vigabatrin‐naïve patients with epilepsy, including those who received treatment with other GABAergic antiepileptic therapy. We also reviewed published data suggesting an association between vigabatrin‐associated retinal toxicity and taurine deficiency,...</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5389791</comments>
            <pubDate>Thu, 10 Nov 2011 14:10:24 +0100</pubDate>
            <guid isPermaLink="false">5389791</guid>        </item>
        <item>
            <title>Primer on visual field testing, electroretinography, and other visual assessments for patients treated with vigabatrin</title>
            <link>http://www.medworm.com/index.php?rid=5389790&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01600.x</link>
            <description>This article provides an overview of visual field testing procedures and electroretinography, summarizes the clinical characteristics of vigabatrin‐associated pVFDs, and provides recommendations for visual field and visual electrophysiology testing relevant to both adult and infant patients treated with vigabatrin. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5389790</comments>
            <pubDate>Thu, 10 Nov 2011 14:10:22 +0100</pubDate>
            <guid isPermaLink="false">5389790</guid>        </item>
        <item>
            <title>Vigabatrin therapy for infantile spasms: review of major trials in Europe, Canada, and the United States; and recommendations for dosing</title>
            <link>http://www.medworm.com/index.php?rid=5389789&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01599.x</link>
            <description>Carmant L. Vigabatrin therapy for infantile spasms: review of major trials in Europe, Canada, and the United States; and recommendations for dosing. Acta Neurol Scand: 2011: 124 (Suppl. 192): 36–47. © 2011 John Wiley &amp; Sons A/S.Infantile spasms (IS) are a unique and severe form of epilepsy associated with poor neurologic and developmental outcomes. The refractory spasms and abnormal electroencephalogram (EEG) patterns associated with the condition are believed to have a progressively detrimental impact. Therefore, rapid and complete control of spasms is the primary goal of treatment. Well‐controlled clinical trials in Europe, Canada, and the United States have demonstrated that vigabatrin is efficacious and generally well‐tolerated as monotherapy for IS. Several key studies,...</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5389789</comments>
            <pubDate>Thu, 10 Nov 2011 14:10:20 +0100</pubDate>
            <guid isPermaLink="false">5389789</guid>        </item>
        <item>
            <title>Vigabatrin therapy for refractory complex partial seizures: review of clinical trial experience in the United States</title>
            <link>http://www.medworm.com/index.php?rid=5389788&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01598.x</link>
            <description>Faught E. Vigabatrin therapy for refractory complex partial seizures: review of clinical trial experience in the United States. Acta Neurol Scand: 2011: 124 (Suppl. 192): 29–35. © 2011 John Wiley &amp; Sons A/S.Vigabatrin is an antiepileptic drug used in more than 50 countries as adjunctive therapy for the treatment of refractory complex partial seizures (rCPS) in adults. First approved in the United Kingdom in 1989, vigabatrin was approved for use in the United States by the Food and Drug Administration in 2009. Although most clinical trials of vigabatrin have been conducted in Europe, three major trials, including two pivotal trials, were conducted in the United States. These trials have demonstrated efficacy and tolerability findings similar to those observed from the European tr...</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5389788</comments>
            <pubDate>Thu, 10 Nov 2011 14:10:19 +0100</pubDate>
            <guid isPermaLink="false">5389788</guid>        </item>
        <item>
            <title>Vigabatrin therapy for refractory complex partial seizures: review of major European trials</title>
            <link>http://www.medworm.com/index.php?rid=5389787&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01597.x</link>
            <description>Ben‐Menachem E, Sander JW. Vigabatrin therapy for refractory complex partial seizures: review of major European trials. Acta Neurol Scand: 2011: 124 (Suppl. 192): 16–28. © 2011 John Wiley &amp; Sons A/S.Complex partial seizures (CPS) are a form of localization‐related seizures associated with serious comorbidities and risks. CPS can be difficult to treat and may remain refractory to treatment with antiepileptic drugs (AEDs). Refractory CPS (rCPS) can be hazardous because of the potential for severe dysfunction and bodily harm, sometimes with fatal consequences. Control of seizure activity is critical to the clinical management of CPS. Vigabatrin is a unique AED approved in both Europe and the United States as adjunctive therapy for adult patients with rCPS who have responded ina...</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5389787</comments>
            <pubDate>Thu, 10 Nov 2011 14:10:17 +0100</pubDate>
            <guid isPermaLink="false">5389787</guid>        </item>
        <item>
            <title>Mechanism of action of vigabatrin: correcting misperceptions</title>
            <link>http://www.medworm.com/index.php?rid=5389786&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01596.x</link>
            <description>Ben‐Menachem E. Mechanism of action of vigabatrin: correcting misperceptions. Acta Neurol Scand: 2011: 124 (Suppl. 192): 5–15. © 2011 John Wiley &amp; Sons A/S.Discovered more than three decades ago, vigabatrin is approved in more than 50 countries as adjunctive therapy for adult patients with refractory complex partial seizures who have responded inadequately to several alternative treatments and as monotherapy for pediatric patients aged 1 month to 2 years with infantile spasms. Contrary to a fairly common misperception, the compound’s mechanism of action is very well‐characterized in animal models and cell cultures. γ‐Aminobutyric acid (GABA)‐ergic synapses comprise approximately 30% of all synapses within the central nervous system, and therein underlies the prima...</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5389786</comments>
            <pubDate>Thu, 10 Nov 2011 14:10:16 +0100</pubDate>
            <guid isPermaLink="false">5389786</guid>        </item>
        <item>
            <title>Vigabatrin 35 years later — from mechanism of action to benefit–risk considerations</title>
            <link>http://www.medworm.com/index.php?rid=5389785&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01606.x</link>
            <description>Shields WD, Pellock JM. Vigabatrin 35 years later — from mechanism of action to benefit–risk considerations. Acta Neurol Scand: 2011: 124 (Suppl. 192): 1–4. © 2011 John Wiley &amp; Sons A/S. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5389785</comments>
            <pubDate>Thu, 10 Nov 2011 14:10:14 +0100</pubDate>
            <guid isPermaLink="false">5389785</guid>        </item>
        <item>
            <title>MR spectroscopy and atrophy in Gluten, Friedreich’s and SCA6 ataxias</title>
            <link>http://www.medworm.com/index.php?rid=5389781&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01620.x</link>
            <description>Conclusions –  This study suggests that 1H‐MRS of the cerebellum in patients with ataxia provides information in addition to the presence of atrophy. There are significant 1H‐MRS differences amongst different types of ataxia with interesting correlations between atrophy and NAA/Cr. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5389781</comments>
            <pubDate>Thu, 10 Nov 2011 14:08:05 +0100</pubDate>
            <guid isPermaLink="false">5389781</guid>        </item>
        <item>
            <title>Biological correlates of post‐stroke fatigue: a systematic review</title>
            <link>http://www.medworm.com/index.php?rid=5389783&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01618.x</link>
            <description>Kutlubaev MA, Duncan FH, Mead GE. Biological correlates of post‐stroke fatigue: a systematic review.  Acta Neurol Scand: DOI: 10.1111/j.1600‐0404.2011.01618.x.  © 2011 John Wiley &amp; Sons A/S.Fatigue is a common and disabling consequence of stroke. Its mechanisms are unknown. Neuroanatomical abnormalities (e.g. white matter lesions, brain atrophy), neuroendocrine dysregulation, neurotransmitter changes and inflammation are associated with fatigue in conditions other than stroke. This review sought to identify published studies describing associations between post‐stroke fatigue and these biological factors. We searched Medline, EMBASE, CINAHL, PsycINFO and AMED on October 15 and PubMed on 28 December 2010 and included studies in English that recruited at least 10 patients (&amp;gt...</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5389783</comments>
            <pubDate>Thu, 10 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5389783</guid>        </item>
        <item>
            <title>Minimizing pharmacodynamic interactions of high doses of lacosamide</title>
            <link>http://www.medworm.com/index.php?rid=5389782&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01619.x</link>
            <description>Conclusion –  s – Drug‐resistant patients rapidly titrated to high doses of lacosamide with simultaneous tapering of traditional sodium channel AEDs had marked reduction in CNS‐related adverse events compared with patients treated in three previous pivotal trials that used fixed doses of concomitant AEDs. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5389782</comments>
            <pubDate>Thu, 10 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5389782</guid>        </item>
        <item>
            <title>Factors associated with lobar vs. non‐lobar intracerebral hemorrhage</title>
            <link>http://www.medworm.com/index.php?rid=5389784&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01615.x</link>
            <description>Conclusions –  Alongside risk factors conventionally thought to be related to LH, underweight may also be a LH‐related factor, specifically in the elderly. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5389784</comments>
            <pubDate>Wed, 09 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5389784</guid>        </item>
        <item>
            <title>Genetic polymorphisms of human β‐defensins in patients with ischemic stroke</title>
            <link>http://www.medworm.com/index.php?rid=5365272&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01613.x</link>
            <description>Conclusions –  The low copy number of the DEFB4 gene, involving a weakened antimicrobial defense of the host, might be important in the pathogenesis of stroke. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5365272</comments>
            <pubDate>Thu, 03 Nov 2011 22:47:09 +0100</pubDate>
            <guid isPermaLink="false">5365272</guid>        </item>
        <item>
            <title>Dravet syndrome – considerable delay in making the diagnosis</title>
            <link>http://www.medworm.com/index.php?rid=5365274&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01609.x</link>
            <description>Conclusions –  By making an early diagnosis, an extensive presurgical evaluation may be avoided, and the patient and their parents may be offered genetic guidance. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5365274</comments>
            <pubDate>Wed, 02 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5365274</guid>        </item>
        <item>
            <title>Treatment of steroid‐unresponsive optic neuritis with plasma exchange</title>
            <link>http://www.medworm.com/index.php?rid=5365273&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01612.x</link>
            <description>Conclusions –  To our knowledge, our study is the largest case series of patients with steroid‐unresponsive ON treated with PE. Based on our experience, we conclude that PE is an important treatment option for patients with steroid‐unresponsive ON although placebo‐controlled studies are missing until now. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5365273</comments>
            <pubDate>Wed, 02 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5365273</guid>        </item>
        <item>
            <title>Incidence of amyotrophic lateral sclerosis in the Faroe Islands</title>
            <link>http://www.medworm.com/index.php?rid=5365276&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01611.x</link>
            <description>Conclusion –  The data clearly suggest, however, that the Faroese population is probably not subject to an increased risk of ALS, even though certain risk factors are present in the general population: (i) a fish‐based diet contaminated with mercury and polychlorinated biphenyl; (ii) the high occurrence of the recessive carnitine transporter genetic defect; and (iii) the anticipated high degree of inbreeding at the fifth generation. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5365276</comments>
            <pubDate>Sat, 29 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5365276</guid>        </item>
        <item>
            <title>Animal model for sport‐related concussion; ICP and cognitive function</title>
            <link>http://www.medworm.com/index.php?rid=5365275&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01614.x</link>
            <description>Conclusion –  Multiple impacts to the head raise intracranial pressure and impair cognitive function and exploratory activity in this animal model. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5365275</comments>
            <pubDate>Sat, 29 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5365275</guid>        </item>
        <item>
            <title>Previously unknown thyroid dysfunction in patients with acute ischemic stroke</title>
            <link>http://www.medworm.com/index.php?rid=5365277&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01604.x</link>
            <description>Conclusions –  In patients with first‐time acute ischemic stroke, unknown thyroid dysfunction is common, and unknown overt or subclinical hyperthyroidism is associated with cardio‐embolic stroke. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5365277</comments>
            <pubDate>Fri, 28 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5365277</guid>        </item>
        <item>
            <title>Episodes of exercise‐induced dark urine and myalgia in LGMD 2I</title>
            <link>http://www.medworm.com/index.php?rid=5365278&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01608.x</link>
            <description>Conclusions –  We conclude that episodes compatible with exercise‐induced myoglobinuria may be frequent in LGMD2I. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5365278</comments>
            <pubDate>Thu, 27 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5365278</guid>        </item>
        <item>
            <title>Heart rate variability in Parkinson’s disease unaffected by deep brain stimulation</title>
            <link>http://www.medworm.com/index.php?rid=5338049&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.1605.x</link>
            <description>Conclusions –  STN‐DBS offered no considerable impact on autonomic cardiovascular control. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5338049</comments>
            <pubDate>Sun, 23 Oct 2011 01:54:12 +0100</pubDate>
            <guid isPermaLink="false">5338049</guid>        </item>
        <item>
            <title>Neurological complications of venomous snake bites: a review</title>
            <link>http://www.medworm.com/index.php?rid=5316799&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01593.x</link>
            <description>Del Brutto OH, Del Brutto VJ. Neurological complications of venomous snake bites: a review. Acta Neurol Scand: DOI: 10.1111/j.1600‐0404.2011.01593.x. © 2011 John Wiley &amp; Sons A/S.Abstract –  Snake bite envenoming is a neglected tropical disease affecting millions of people living in the developing world. According to the offending snake species, the clinical picture may be dominated by swelling and soft tissue necrosis in the bitten limb, or by systemic or neurological manifestations. Serious neurological complications, including stroke and muscle paralysis, are related to the toxic effects of the venom, which contains a complex mixture of toxins affecting the coagulation cascade, the neuromuscular transmission, or both. Metalloproteinases, serine proteases, and C‐type l...</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5316799</comments>
            <pubDate>Sat, 15 Oct 2011 14:59:17 +0100</pubDate>
            <guid isPermaLink="false">5316799</guid>        </item>
        <item>
            <title>Two galantamine titration regimens in patients switched from donepezil</title>
            <link>http://www.medworm.com/index.php?rid=5316801&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01594.x</link>
            <description>Conclusions –  Patients in whom donepezil is ineffective or poorly tolerated may benefit from a switch to galantamine. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5316801</comments>
            <pubDate>Thu, 13 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5316801</guid>        </item>
        <item>
            <title>Post‐stroke depression and functional independence: a conundrum</title>
            <link>http://www.medworm.com/index.php?rid=5316800&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01595.x</link>
            <description>Conclusions –  The differences found in levels of depression between those with lower functional independence after a stroke compared to those more independent in P‐ADL, raise the possibility that attention should be paid to therapeutic rehabilitation for stroke patients to help them recover as much functional independence as possible in order to improve their quality of life and lower their chances of developing PSD. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5316800</comments>
            <pubDate>Thu, 13 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5316800</guid>        </item>
        <item>
            <title>Response: progesterone levels in amyotrophic lateral sclerosis</title>
            <link>http://www.medworm.com/index.php?rid=5287332&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01534.x</link>
            <description>(Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5287332</comments>
            <pubDate>Thu, 06 Oct 2011 12:27:36 +0100</pubDate>
            <guid isPermaLink="false">5287332</guid>        </item>
        <item>
            <title>Progesterone levels in amyotrophic lateral sclerosis</title>
            <link>http://www.medworm.com/index.php?rid=5287331&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01531.x</link>
            <description>(Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5287331</comments>
            <pubDate>Thu, 06 Oct 2011 12:27:35 +0100</pubDate>
            <guid isPermaLink="false">5287331</guid>        </item>
        <item>
            <title>Alzheimer CSF biomarkers in routine clinical setting</title>
            <link>http://www.medworm.com/index.php?rid=5262498&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01592.x</link>
            <description>Conclusions –  The interest of biomarkers and their ability to solve awkward cases were carefully noticed all the more when a discrepancy between clinical and CSF biological data was involved. The final proposed algorithm allowed to identify pathogenic forms of AD according to the prevailing role of hyperphosphorylated tau or amyloid beta peptide. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5262498</comments>
            <pubDate>Thu, 29 Sep 2011 13:33:18 +0100</pubDate>
            <guid isPermaLink="false">5262498</guid>        </item>
        <item>
            <title>Response: inflammatory molecules in ALS</title>
            <link>http://www.medworm.com/index.php?rid=5239836&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01502.x</link>
            <description>(Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5239836</comments>
            <pubDate>Thu, 22 Sep 2011 13:42:26 +0100</pubDate>
            <guid isPermaLink="false">5239836</guid>        </item>
        <item>
            <title>Interleukin‐17 and ‐23 levels in amyotrophic lateral sclerosis</title>
            <link>http://www.medworm.com/index.php?rid=5239835&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01501.x</link>
            <description>(Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5239835</comments>
            <pubDate>Thu, 22 Sep 2011 13:42:24 +0100</pubDate>
            <guid isPermaLink="false">5239835</guid>        </item>
        <item>
            <title>[123I]FP‐CIT‐SPECT asymmetry index to differentiate Parkinson’s disease from vascular parkinsonism</title>
            <link>http://www.medworm.com/index.php?rid=5228005&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01583.x</link>
            <description>Conclusions –  SAI detected using [123I]FP‐CIT SPECT can be used to differentiate VP and PD with a good degree of certainty. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5228005</comments>
            <pubDate>Wed, 14 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5228005</guid>        </item>
        <item>
            <title>Prognosis and prognostic factors in sporadic inclusion body myositis</title>
            <link>http://www.medworm.com/index.php?rid=5228004&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01584.x</link>
            <description>Conclusions –  There is a mean of 1% loss in power per month in the untreated IBM patient – the rate of loss was greater in the quadriceps muscle and in untreated compared with IS‐treated patients. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5228004</comments>
            <pubDate>Wed, 14 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5228004</guid>        </item>
        <item>
            <title>Obstructive sleep apnea and biomarkers of inflammation in ischemic stroke</title>
            <link>http://www.medworm.com/index.php?rid=5228003&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01589.x</link>
            <description>Conclusions –  IL‐6, an atherogenic marker, shows a commensurate increase in stroke patients with OSA. It is correlated with oxyhemoglobin desaturation and with desaturation index and may be a surrogate measure to evaluate continuous positive airway pressure therapy. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5228003</comments>
            <pubDate>Wed, 14 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5228003</guid>        </item>
        <item>
            <title>Development of a disability scale for myotonic dystrophy type 1</title>
            <link>http://www.medworm.com/index.php?rid=5211033&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01587.x</link>
            <description>Discussion –  Our scale provides a new practical measure to evaluate NI and disability of DM1 patients. Further longitudinal studies are warranted to confirm its reliability in tracking disease progression and severity over a longer period of time. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5211033</comments>
            <pubDate>Thu, 08 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5211033</guid>        </item>
        <item>
            <title>Vasomotor reactivity as a predictor for syncope in patients with orthostatism</title>
            <link>http://www.medworm.com/index.php?rid=5228002&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01591.x</link>
            <description>Conclusions –  Among patients with OH, we found an association between the presence of syncope and impaired VMR. Assessment of VMR among patients with OH may predict those who are at higher risk to faint and fall and to support more aggressive intervention. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5228002</comments>
            <pubDate>Thu, 01 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5228002</guid>        </item>
        <item>
            <title>Craniotomy for brain metastases: a consecutive series of 316 patients</title>
            <link>http://www.medworm.com/index.php?rid=5211032&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01590.x</link>
            <description>Conclusions –  In this population study, the annual incidence of a first‐time craniotomy for a brain metastasis was 2.6/100,000, the 30‐day mortality rate was 3.8%, and median OS was 9.2 months. The well‐known prognostic factors were confirmed. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5211032</comments>
            <pubDate>Thu, 01 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5211032</guid>        </item>
        <item>
            <title>Tolerability and safety of perampanel: two randomized dose‐escalation studies</title>
            <link>http://www.medworm.com/index.php?rid=5171226&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01588.x</link>
            <description>Conclusions –  Perampanel was well tolerated across doses of 4–12 mg/day. The studies showed preliminary evidence of efficacy and identified doses to be evaluated in larger clinical studies. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5171226</comments>
            <pubDate>Mon, 29 Aug 2011 17:22:30 +0100</pubDate>
            <guid isPermaLink="false">5171226</guid>        </item>
        <item>
            <title>MRI and visual‐evoked potentials in partners of multiple sclerosis patients</title>
            <link>http://www.medworm.com/index.php?rid=5164359&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01586.x</link>
            <description>Conclusion –  The finding of one conjugal pair and abnormal VEP in a further four MS partners could have several explanations. It is compatible with the concept of a transmissible agent, although our observations could be due to several biases as well as the play of chance alone. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5164359</comments>
            <pubDate>Sat, 27 Aug 2011 17:40:00 +0100</pubDate>
            <guid isPermaLink="false">5164359</guid>        </item>
        <item>
            <title>Corrigendum</title>
            <link>http://www.medworm.com/index.php?rid=5111308&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01570.x</link>
            <description>(Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5111308</comments>
            <pubDate>Wed, 10 Aug 2011 22:01:04 +0100</pubDate>
            <guid isPermaLink="false">5111308</guid>        </item>
        <item>
            <title>Acute stroke centre – the changing focus of stroke unit care. The Bergen NORSTROKE Study</title>
            <link>http://www.medworm.com/index.php?rid=5111304&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01582.x</link>
            <description>Conclusion –  An acute stroke centre today requires a high degree of neurological expertise in assessing patients admitted with possible stroke. Most patients with stroke have no or mild deficits and need above all rapid diagnostic work‐up, acute and prophylactic treatment. In‐hospital rehabilitation is essential for a smaller number of patients who suffer from persisting neurological deficits after stroke. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5111304</comments>
            <pubDate>Wed, 10 Aug 2011 22:00:02 +0100</pubDate>
            <guid isPermaLink="false">5111304</guid>        </item>
        <item>
            <title>Expression of hepatocyte growth factor in the skin of amyotrophic lateral sclerosis</title>
            <link>http://www.medworm.com/index.php?rid=5111307&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01579.x</link>
            <description>Conclusions –  These findings suggest that changes in HGF in ALS skin are related to the disease process and that metabolic alterations of HGF may take place in the skin of patients with ALS. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5111307</comments>
            <pubDate>Mon, 08 Aug 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5111307</guid>        </item>
        <item>
            <title>Impact of screening with thyroid ultrasonography in myasthenia gravis patients</title>
            <link>http://www.medworm.com/index.php?rid=5111306&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01580.x</link>
            <description>Conclusions –  Our data suggest that the prevalence of thyroid carcinoma in cases of MG may be higher than that of the general population. Furthermore, in patients with MG, there is a possibility that the stage of the carcinoma is higher even when the carcinoma is of a very small size. Patients with MG, when diagnosed, should be advised to undergo US screening of the thyroid because most cases of thyroid carcinoma are highly curable. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5111306</comments>
            <pubDate>Mon, 08 Aug 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5111306</guid>        </item>
        <item>
            <title>Family recurrence and oligo‐anuria predict uremic restless legs syndrome</title>
            <link>http://www.medworm.com/index.php?rid=5111305&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01581.x</link>
            <description>Conclusion –  Positive family history for RLS together with reduced/absent residual renal function and peripheral neuropathy predicts the risk for RLS in ESKD patients undergoing HD. Longitudinal studies are warranted to correlate RLS occurrence with genetic and environmental factors. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5111305</comments>
            <pubDate>Mon, 08 Aug 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5111305</guid>        </item>
        <item>
            <title>Risk factors for aneurysmal subarachnoid hemorrhage – BMI and serum lipids: 11‐year follow‐up of the HUNT and the Tromsø Study in Norway</title>
            <link>http://www.medworm.com/index.php?rid=5071859&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01578.x</link>
            <description>Conclusions –  Overweight may be associated with reduced risk of aSAH, but there was no over all association of total serum cholesterol, HDL cholesterol, or triglycerides with the risk of aSAH in this prospective study. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5071859</comments>
            <pubDate>Fri, 29 Jul 2011 14:15:54 +0100</pubDate>
            <guid isPermaLink="false">5071859</guid>        </item>
        <item>
            <title>Incidence of multiple sclerosis in Chile. A hospital registry study</title>
            <link>http://www.medworm.com/index.php?rid=5071860&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01571.x</link>
            <description>Conclusion –  There is a moderate risk of MS in Chile. The southernmost region showed significantly higher incidence rates than those in the rest of the country (a cluster zone). We did not find any correlation between incidence rates and latitude or UV radiation. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5071860</comments>
            <pubDate>Wed, 27 Jul 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5071860</guid>        </item>
        <item>
            <title>Cognitive deficits in multiple sclerosis: correlations with T2 changes in normal appearing brain tissue</title>
            <link>http://www.medworm.com/index.php?rid=5071861&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01574.x</link>
            <description>Conclusion –  Our results suggest that even in the NABT MR detects changes likely to be associated with an underlying pathology and possibly contributes to the cognitive impairment in MS. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5071861</comments>
            <pubDate>Tue, 26 Jul 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5071861</guid>        </item>
        <item>
            <title>Intrathecal levels of vitamin D and IgG in multiple sclerosis</title>
            <link>http://www.medworm.com/index.php?rid=5054149&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01577.x</link>
            <description>Conclusion –  Physiological variation in vitamin D does not exert a major impact on intrathecal synthesis of IgG in MS. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5054149</comments>
            <pubDate>Sat, 23 Jul 2011 18:39:18 +0100</pubDate>
            <guid isPermaLink="false">5054149</guid>        </item>
        <item>
            <title>Correlation between crossed cerebellar diaschisis and clinical neurological scales</title>
            <link>http://www.medworm.com/index.php?rid=5054150&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01576.x</link>
            <description>Conclusions –  The findings indicate that DoD can be used as a quantitative indicator of the functional impairments following stroke, i.e. it can serve as a potential surrogate of the severity of the damage. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5054150</comments>
            <pubDate>Fri, 22 Jul 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5054150</guid>        </item>
        <item>
            <title>Non‐motor features in essential tremor</title>
            <link>http://www.medworm.com/index.php?rid=5041641&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01573.x</link>
            <description>Conclusion –  There was a significantly higher prevalence and greater severity of sleep disturbances, fatigue, pain, anxiety, and depression in patients with ET and depression significantly affected the QOL. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5041641</comments>
            <pubDate>Wed, 20 Jul 2011 20:51:12 +0100</pubDate>
            <guid isPermaLink="false">5041641</guid>        </item>
        <item>
            <title>Epilepsia partialis continua in tick‐borne Russian spring‐summer encephalitis</title>
            <link>http://www.medworm.com/index.php?rid=5041642&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01575.x</link>
            <description>Conclusion –  EPC caused by TBRSSE is relatively frequent in the Eastern parts of the Russian Federation but not west of the Ural. Unlike Rasmussen encephalitis, EPC with TBRSSE does not progress even in the long term. It appears as disabling but not fatal condition with a time course where three phases can be distinguished. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5041642</comments>
            <pubDate>Mon, 18 Jul 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5041642</guid>        </item>
        <item>
            <title>SOX1 antibodies in sera from patients with paraneoplastic neurological syndromes</title>
            <link>http://www.medworm.com/index.php?rid=5031855&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01572.x</link>
            <description>Conclusions– We describe SOX1 reactivity for the first time overlapping with CV2/CRMP5 and amphiphysin antibodies. SOX1 reactivity is predominantly associated with Hu antibodies and SCLC, but can occur also in other types of lung cancer. Neurological manifestations present in patients with coexisting SOX1 antibodies and well‐characterized antineuronal antibodies do not differ from those previously described in patients positive for antineuronal antibodies but no SOX1‐specific anti‐glial antibodies. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5031855</comments>
            <pubDate>Sun, 17 Jul 2011 00:27:44 +0100</pubDate>
            <guid isPermaLink="false">5031855</guid>        </item>
        <item>
            <title>Absence of cardiovascular disease risk factors in restless legs syndrome</title>
            <link>http://www.medworm.com/index.php?rid=4987459&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01563.x</link>
            <description>Conclusion –  Our findings argue against the presence of an altered lipid metabolism as a risk factor for the development of cerebrovascular disease in patients with RLS, even if they do support the idea that cerebrovascular disease might be frequent in this condition. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4987459</comments>
            <pubDate>Fri, 01 Jul 2011 21:00:53 +0100</pubDate>
            <guid isPermaLink="false">4987459</guid>        </item>
        <item>
            <title>Keyword index</title>
            <link>http://www.medworm.com/index.php?rid=4978646&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01569.x</link>
            <description>(Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4978646</comments>
            <pubDate>Wed, 29 Jun 2011 19:47:52 +0100</pubDate>
            <guid isPermaLink="false">4978646</guid>        </item>
        <item>
            <title>Bone health in adults with epilepsy</title>
            <link>http://www.medworm.com/index.php?rid=4978645&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01551.x</link>
            <description>Svalheim S, Røste LS, Nakken KO, Taubøll E. Bone health in adults with epilepsy. Acta Neurol Scand: 2011: 124 (Suppl. 191): 89–95. © 2011 John Wiley &amp; Sons A/S.Patients with epilepsy have a 2–6 times greater risk of bone fractures compared with the general population. There are several potential explanations. Some fractures are caused by seizure‐related injuries, or they may be associated with the osteopenic effect of reduced physical activity in patients with epilepsy. Antiepileptic drugs (AEDs), especially those that affect the liver enzymes, e.g., phenytoin, carbamazepine, phenobarbital, as well as valproate, are also associated with increased fracture rate and low bone mineral density. Many patients with epilepsy and general practitioners seem unaware of this problem. ...</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4978645</comments>
            <pubDate>Wed, 29 Jun 2011 19:47:51 +0100</pubDate>
            <guid isPermaLink="false">4978645</guid>        </item>
        <item>
            <title>Onconeural antibodies in patients with neurological symptoms: detection and clinical significance</title>
            <link>http://www.medworm.com/index.php?rid=4978644&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01549.x</link>
            <description>Conclusions –  The onconeural antibodies are directed against intracellular antigens and their pathogenic role is still largely unknown. They are highly specific markers of paraneoplastic aetiology in patients with neurological symptoms. Detection of an onconeural antibody in a patient with neurological symptoms should lead to prompt investigation for cancer. However, absence of detectable onconeural antibodies does not exclude the PNS diagnosis. In particular, failure to detect antibodies in patients without classical PNS symptoms may result in less vigorous cancer screening and diagnostic delay. Neuronal antibodies that are directed to synaptic proteins or proteins of the cell membrane are also associated with neurological symptoms, and probably have pathogenic effects. The associat...</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4978644</comments>
            <pubDate>Wed, 29 Jun 2011 19:47:51 +0100</pubDate>
            <guid isPermaLink="false">4978644</guid>        </item>
        <item>
            <title>Fractures and falls in patients with newly diagnosed clinically isolated syndrome and multiple sclerosis</title>
            <link>http://www.medworm.com/index.php?rid=4978643&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01548.x</link>
            <description>Conclusions –  Fall tendency may occur early in the disease course of MS, before impairment of locomotion and balance becomes evident on clinical examination. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4978643</comments>
            <pubDate>Wed, 29 Jun 2011 19:47:50 +0100</pubDate>
            <guid isPermaLink="false">4978643</guid>        </item>
        <item>
            <title>Cardiovascular and urological dysfunction in spinal cord injury</title>
            <link>http://www.medworm.com/index.php?rid=4978642&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01547.x</link>
            <description>Conclusions –  Patients with SCI have a high risk of cardiovascular complications, AD and urinary autonomic dysfunction both in the acute phase and later, affecting their prognosis and quality of life. Knowledge of cardiovascular and urological complications after SCI is important for proper diagnosis and treatment. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4978642</comments>
            <pubDate>Wed, 29 Jun 2011 19:47:49 +0100</pubDate>
            <guid isPermaLink="false">4978642</guid>        </item>
        <item>
            <title>Nerve biopsy – some comments on procedures and indications</title>
            <link>http://www.medworm.com/index.php?rid=4978641&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01546.x</link>
            <description>Mellgren SI, Lindal S. Nerve biopsy – some comments on procedures and indications. Acta Neurol Scand: 2011: 124 (Suppl. 191): 64–70. © 2011 John Wiley &amp; Sons A/S.Nerve biopsy is most often a final step in the evaluation of patients with peripheral neuropathy. The procedure should always be expected to result in varying degree of sensory loss within the innervation area of the biopsied nerve and chronic pain in the area may also occur. Therefore appropriate informed consent must be obtained and a weighing of such side effects and benefits for the patient, particularly therapeutical consequences, should be seriously considered before the procedure is performed. The surgical procedure and the processing in the laboratory of the nerve material must hold a high standard at all leve...</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4978641</comments>
            <pubDate>Wed, 29 Jun 2011 19:47:49 +0100</pubDate>
            <guid isPermaLink="false">4978641</guid>        </item>
        <item>
            <title>What initiates a migraine attack? Conclusions from four longitudinal studies of quantitative EEG and steady‐state visual‐evoked potentials in migraineurs</title>
            <link>http://www.medworm.com/index.php?rid=4978640&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01545.x</link>
            <description>Conclusions from four longitudinal studies of quantitative EEG and steady‐state visual‐evoked potentials in migraineurs. Acta Neurol Scand: 2011: 124 (Suppl. 191): 56–63. © 2011 John Wiley &amp; Sons A/S.Objectives –  Quantitative electroencephalograpic (QEEG) frequency spectra and steady‐state visual‐evoked potentials (SSVEP) are indicators of corticothalamic excitability (e.g., arousal). Increased interictal excitability is suggested to be an important element in the migraine pathophysiology. In this paper, we summarize our results from four studies of QEEG and SSVEP recordings in migraineurs interictally and in the days before an attack with the intention to shed light on attack‐initiating mechanisms.Material and methods –  Thirty‐two healthy controls, 33 mi...</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4978640</comments>
            <pubDate>Wed, 29 Jun 2011 19:47:48 +0100</pubDate>
            <guid isPermaLink="false">4978640</guid>        </item>
        <item>
            <title>Botulinum toxin treatment of secondary headaches and cranial neuralgias: a review of evidence</title>
            <link>http://www.medworm.com/index.php?rid=4978639&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01544.x</link>
            <description>Conclusion –  At present, BoNT cannot be firmly recommended as an evidence‐based treatment in secondary headaches or cranial neuralgias. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4978639</comments>
            <pubDate>Wed, 29 Jun 2011 19:47:47 +0100</pubDate>
            <guid isPermaLink="false">4978639</guid>        </item>
        <item>
            <title>Multiple sclerosis, a cause of secondary osteoporosis? What is the evidence and what are the clinical implications?</title>
            <link>http://www.medworm.com/index.php?rid=4978638&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01543.x</link>
            <description>Conclusion –  We argue that MS, like a number of other chronic diseases, is a cause of secondary osteoporosis. Therefore, bone health assessment should be a part of the integral management of persons with MS. We suggest that BMD be measured shortly after diagnosis, that BMD measurements be repeated depending on BMD values and individual osteoporosis risk profile, and that serum 25‐hydroxyvitamin D be monitored. All persons with MS should receive bone health advice. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4978638</comments>
            <pubDate>Wed, 29 Jun 2011 19:47:46 +0100</pubDate>
            <guid isPermaLink="false">4978638</guid>        </item>
        <item>
            <title>A randomized controlled trial on medication‐overuse headache: outcome after 1 and 4 years</title>
            <link>http://www.medworm.com/index.php?rid=4978637&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01542.x</link>
            <description>Discussion –  Early introduction of prophylactic medication was an effective way to reduce headache days during the first 3 months, and the notion that patients with MOH need withdrawal of analgesics to respond to preventive medication seems to be incorrect. The long‐term prognosis during the 4‐year follow‐up was relatively favorable as there was a steady decline in headache, one‐third of the patients with MOH having ≥50% reduction in headache frequency from baseline and two‐thirds being without medication overuse. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4978637</comments>
            <pubDate>Wed, 29 Jun 2011 19:47:46 +0100</pubDate>
            <guid isPermaLink="false">4978637</guid>        </item>
        <item>
            <title>Ischemic stroke – novel therapeutic strategies</title>
            <link>http://www.medworm.com/index.php?rid=4978636&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01540.x</link>
            <description>Conclusions –  Sufficiently powered RCTs to evaluate the effect of thrombectomy with mechanical devices are warranted, but as the natural course of a large vessel stroke carries a devastating prognosis, a proactive recanalization approach is justified based on today’s knowledge. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4978636</comments>
            <pubDate>Wed, 29 Jun 2011 19:47:45 +0100</pubDate>
            <guid isPermaLink="false">4978636</guid>        </item>
        <item>
            <title>Haematological side effects of antiepileptic drug treatment in patients with epilepsy</title>
            <link>http://www.medworm.com/index.php?rid=4978635&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01539.x</link>
            <description>Conclusions –  Both men and women treated with LEV monotherapy have lower blood platelet counts than healthy controls, with no difference in Hb or WBC. Haematological changes observed with the other AEDs were minor. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4978635</comments>
            <pubDate>Wed, 29 Jun 2011 19:47:44 +0100</pubDate>
            <guid isPermaLink="false">4978635</guid>        </item>
        <item>
            <title>Subclinical carotid atherosclerosis and cognitive function</title>
            <link>http://www.medworm.com/index.php?rid=4978634&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01538.x</link>
            <description>Arntzen KA, Mathiesen EB. Subclinical carotid atherosclerosis and cognitive function. Acta Neurol Scand: 2011: 124 (Suppl. 191): 18–22. © 2011 John Wiley &amp; Sons A/S.Carotid artery atherosclerosis is a major risk factor for stroke and subsequent cognitive impairment. Recent studies indicate that carotid atherosclerosis without clinical stroke may also be an independent risk factor for cognitive decline and dementia. Ultrasonography is an easily assessable and non‐invasive method to measure different stages of the carotid artery atherosclerotic process and is widely used in clinical assessment as well as in epidemiological and clinical research. We give a brief review of studies that have investigated degrees of the subclinical atherosclerosis in the carotid arteries in relation...</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4978634</comments>
            <pubDate>Wed, 29 Jun 2011 19:47:43 +0100</pubDate>
            <guid isPermaLink="false">4978634</guid>        </item>
        <item>
            <title>Gender differences in risk‐taking behaviour in youth with epilepsy: a Norwegian population‐based study</title>
            <link>http://www.medworm.com/index.php?rid=4978633&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01537.x</link>
            <description>Conclusion–  Boys with epilepsy exhibit risk‐taking behaviour more frequently than controls. Other risk factors for this behaviour were living with a single parent, low family income and psychiatric symptoms. This behavioural association should be addressed as it probably contributes to the negative social outcomes that frequently occur in the adult epilepsy population. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4978633</comments>
            <pubDate>Wed, 29 Jun 2011 19:47:43 +0100</pubDate>
            <guid isPermaLink="false">4978633</guid>        </item>
        <item>
            <title>Communication and neurology – bad news and how to break them</title>
            <link>http://www.medworm.com/index.php?rid=4978632&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01550.x</link>
            <description>Storstein A. Communication and neurology – bad news and how to break them. Acta Neurol Scand: 2011: 124 (Suppl. 191): 5–11. © 2011 John Wiley &amp; Sons A/S.How to deliver bad news to patients is a crucial part of medical practice. Many neurological diseases are incurable, progressive and result in physical or cognitive disabilities, which pose special challenges in the process of communication. Information about diagnosis, therapy and prognosis should be given in an appropriate setting and tailored to the patient’s needs and cognitive level of functioning. Support and advice to the family and a team‐oriented approach in the follow‐up of neurological patients are of high importance. Patient autonomy, truth disclosure expectations and the access to other sources of informatio...</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4978632</comments>
            <pubDate>Wed, 29 Jun 2011 19:47:42 +0100</pubDate>
            <guid isPermaLink="false">4978632</guid>        </item>
        <item>
            <title>Partnership and cooperation is necessary to improve and expand neurology</title>
            <link>http://www.medworm.com/index.php?rid=4978631&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01541.x</link>
            <description>Conclusion –  Open‐handedness and a willingness to co‐operate should be a hallmark for neurologists. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4978631</comments>
            <pubDate>Wed, 29 Jun 2011 19:47:41 +0100</pubDate>
            <guid isPermaLink="false">4978631</guid>        </item>
        <item>
            <title>Oral topiramate as an add‐on treatment for refractory status epilepticus</title>
            <link>http://www.medworm.com/index.php?rid=4978619&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01562.x</link>
            <description>Conclusions –  As compared to previous small series describing only patients responding to TPM, this unselected observation underscores the difficulty of treating refractory SE, regardless of the agent. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4978619</comments>
            <pubDate>Wed, 29 Jun 2011 19:46:22 +0100</pubDate>
            <guid isPermaLink="false">4978619</guid>        </item>
        <item>
            <title>Unlocking the locked in; a need for team approach in rehabilitation of survivors with locked‐in syndrome</title>
            <link>http://www.medworm.com/index.php?rid=4978622&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01552.x</link>
            <description>Conclusions –  There is a need for follow‐up not only to re‐assess skills and needs partly owing to new technologies but also to see whether the person needs more assistance to adapt to the alternative means of communication or whether the carers of the person need extra information about communication. We conclude that the low incidence of the syndrome necessitates a skilled team in which different professionals can together assess the person. This probably requires some centralization. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4978622</comments>
            <pubDate>Mon, 27 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4978622</guid>        </item>
        <item>
            <title>Clinical heterogeneity in Parkinson’s disease revisited: a latent profile analysis</title>
            <link>http://www.medworm.com/index.php?rid=4978621&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01561.x</link>
            <description>Conclusion –  LPA holds promise in PD research as it uncovered three PD subtypes distinguished by motor symptoms and disease progression and validated by cognitive variables. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4978621</comments>
            <pubDate>Mon, 27 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4978621</guid>        </item>
        <item>
            <title>Effects of the abrupt switch from solution to modified‐release granule formulation of valproate</title>
            <link>http://www.medworm.com/index.php?rid=4978620&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01568.x</link>
            <description>Conclusion –  Modified‐release granule formulation of VPA may be a reliable alternative to solution for its convenience of use. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4978620</comments>
            <pubDate>Mon, 27 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4978620</guid>        </item>
        <item>
            <title>Myelin glycosphingolipid immunoreactivity and CSF levels in multiple sclerosis</title>
            <link>http://www.medworm.com/index.php?rid=4971566&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01554.x</link>
            <description>Conclusions –  The IgM immunoreactivity in serum did not show any relationship to the type of course or severity of MS, arguing against a phenomenon secondary to myelin damage. Thus, the IgM antibody findings are compatible with an early antigen challenge or autoimmunity associated with natural antibodies. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4971566</comments>
            <pubDate>Mon, 27 Jun 2011 22:33:16 +0100</pubDate>
            <guid isPermaLink="false">4971566</guid>        </item>
        <item>
            <title>Evaluating the use and limitations of the Danish National Patient Register in register‐based research using an example of multiple sclerosis</title>
            <link>http://www.medworm.com/index.php?rid=4971567&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01558.x</link>
            <description>Conclusions –  The low completeness reduces the usefulness of the LPR in epidemiological MS research, in particular incidence studies. The study also found that the completeness of the LPR could be increased to 92.8% by including LPR records from other departments in addition, but this reduced the validity of the LPR to 95.1%. However, these results cannot uncritically be applied to registration of other diseases in the LPR. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4971567</comments>
            <pubDate>Thu, 23 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4971567</guid>        </item>
        <item>
            <title>A Swedish version of the 16‐item Parkinson fatigue scale (PFS‐16)</title>
            <link>http://www.medworm.com/index.php?rid=4955833&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01560.x</link>
            <description>Conclusions –  These observations support the psychometric properties of the Swedish PFS‐16, but cautions against dichotomised scoring. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4955833</comments>
            <pubDate>Wed, 22 Jun 2011 19:52:33 +0100</pubDate>
            <guid isPermaLink="false">4955833</guid>        </item>
        <item>
            <title>Glucose metabolism in small subcortical structures in Parkinson’s disease</title>
            <link>http://www.medworm.com/index.php?rid=4955835&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01556.x</link>
            <description>Conclusion –  The presence and extent of subcortical hypermetabolism in PD is dependent on type of normalization. However, the present findings suggest that PD, in addition to widespread cortical hypometabolism, is probably characterized by true hypermetabolism in the GPe. This finding was predicted by the animal 2‐deoxyglucose autoradiography literature, in which high‐magnitude hypermetabolism was also most robustly detected in the GPe. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4955835</comments>
            <pubDate>Mon, 20 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4955835</guid>        </item>
        <item>
            <title>Post‐stroke fatigue and return to work: a 2‐year follow‐up</title>
            <link>http://www.medworm.com/index.php?rid=4955834&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01557.x</link>
            <description>Conclusions –  Post‐stroke fatigue appears to be an independent determinant of not being able to resume paid work following stroke. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4955834</comments>
            <pubDate>Mon, 20 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4955834</guid>        </item>
        <item>
            <title>Sunlight exposure is important for preventing hip fractures in patients with Alzheimer’s disease, Parkinson’s disease, or stroke</title>
            <link>http://www.medworm.com/index.php?rid=4939686&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01555.x</link>
            <description>Conclusion –  The present meta‐analysis added additional evidence indicating the efficacy of sunlight exposure for reducing the risk of hip fractures in patients with Alzheimer’s disease, Parkinson’s disease, and stroke. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4939686</comments>
            <pubDate>Sat, 18 Jun 2011 19:39:11 +0100</pubDate>
            <guid isPermaLink="false">4939686</guid>        </item>
        <item>
            <title>Comparison of carbamazepine rash in multiple sclerosis and epilepsy</title>
            <link>http://www.medworm.com/index.php?rid=4924567&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01553.x</link>
            <description>Conclusion –  Compared with epilepsy, which is only rarely caused by immunological mechanisms, the autoimmune disorder MS was not associated with a different occurrence of CBZ skin reactions. The trend towards an increased occurrence of rashes in MS can partly be explained by a higher predisposition to CBZ rash in women of fertile age. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4924567</comments>
            <pubDate>Mon, 13 Jun 2011 23:27:52 +0100</pubDate>
            <guid isPermaLink="false">4924567</guid>        </item>
        <item>
            <title>Phenytoin‐induced gingival overgrowth</title>
            <link>http://www.medworm.com/index.php?rid=4915425&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01535.x</link>
            <description>Arya R, Gulati S. Phenytoin‐induced gingival overgrowth. Acta Neurol Scand: DOI: 10.1111/j.1600‐0404.2011.01535.x. © 2011 John Wiley &amp; Sons A/S.Gingival overgrowth is a common adverse effect of therapy with Phenytoin, having important medical and cosmetic implications. Poor periodontal hygiene is an important risk factor for severity of Phenytoin‐induced gingival overgrowth (PIGO), which is a time‐dependent process. There is complex interplay of altered fibroblast biology, connective tissue turnover, inflammatory processes, and growth factors on a background of genetic susceptibility to produce increase in various components of interstitial matrix in PIGO tissue. Treatment options have included change of PHT to another anti‐seizure drug, measures to improve periodontal h...</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4915425</comments>
            <pubDate>Fri, 10 Jun 2011 18:31:07 +0100</pubDate>
            <guid isPermaLink="false">4915425</guid>        </item>
        <item>
            <title>Alterations of T cell subsets in ALS: a systemic immune activation?</title>
            <link>http://www.medworm.com/index.php?rid=4915429&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01528.x</link>
            <description>Conclusions –  Our results suggest a systemic immune activation in patients with ALS. The high production of CD8+ T and NKT cells may suggest an immunological reaction to some unknown or undetected endogenous proteins or viruses. A probably dual (neurodestructive or neuroprotective) inflammatory function of Treg cells cannot be excluded. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4915429</comments>
            <pubDate>Wed, 08 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4915429</guid>        </item>
        <item>
            <title>Primary Sjogren’s syndrome: cognitive symptoms, mood, and cognitive performance</title>
            <link>http://www.medworm.com/index.php?rid=4915427&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01530.x</link>
            <description>Conclusion –  The Prof‐M is a simple self‐report measure which could be useful in screening PSS subjects who may benefit from detailed psychometric evaluation. Our results are consistent with the hypothesis that depression and verbal memory impairment are overlapping but independent aspects of neural involvement in PSS. While pain and depression are significant confounders of cognitive function in PSS, this study suggests that impaired verbal reasoning ability in PSS is not attributable to pain or depression. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4915427</comments>
            <pubDate>Wed, 08 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4915427</guid>        </item>
        <item>
            <title>Implementation of a new CSF dynamic device: a multicenter feasibility study in 562 patients</title>
            <link>http://www.medworm.com/index.php?rid=4915426&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01533.x</link>
            <description>Conclusion –  Infusion testing was safe and without serious adverse events with a high rate of successful procedures. The investigation was associated with expected mild to moderate discomfort. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4915426</comments>
            <pubDate>Wed, 08 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4915426</guid>        </item>
        <item>
            <title>Adult‐onset leukoencephalopathies</title>
            <link>http://www.medworm.com/index.php?rid=4905767&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2010.01439.x</link>
            <description>(Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4905767</comments>
            <pubDate>Wed, 08 Jun 2011 14:00:38 +0100</pubDate>
            <guid isPermaLink="false">4905767</guid>        </item>
        <item>
            <title>White matter disorders with autosomal dominant heredity</title>
            <link>http://www.medworm.com/index.php?rid=4905766&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2010.01438.x</link>
            <description>(Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4905766</comments>
            <pubDate>Wed, 08 Jun 2011 14:00:37 +0100</pubDate>
            <guid isPermaLink="false">4905766</guid>        </item>
        <item>
            <title>Sexual function in multiple sclerosis</title>
            <link>http://www.medworm.com/index.php?rid=4905765&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2010.01458.x</link>
            <description>(Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4905765</comments>
            <pubDate>Wed, 08 Jun 2011 14:00:36 +0100</pubDate>
            <guid isPermaLink="false">4905765</guid>        </item>
        <item>
            <title>Exploring sexual problems among patients with multiple sclerosis</title>
            <link>http://www.medworm.com/index.php?rid=4905764&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2010.01457.x</link>
            <description>(Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4905764</comments>
            <pubDate>Wed, 08 Jun 2011 14:00:36 +0100</pubDate>
            <guid isPermaLink="false">4905764</guid>        </item>
        <item>
            <title>Multiple sclerosis in the Faroe Islands: a core context for neuroanthropology</title>
            <link>http://www.medworm.com/index.php?rid=4905763&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2010.01449.x</link>
            <description>(Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4905763</comments>
            <pubDate>Wed, 08 Jun 2011 14:00:35 +0100</pubDate>
            <guid isPermaLink="false">4905763</guid>        </item>
        <item>
            <title>Tetracycline treatment in patients with progressive external ophthalmoplegia</title>
            <link>http://www.medworm.com/index.php?rid=4905758&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01536.x</link>
            <description>Conclusions –  Further studies are needed to confirm such effects of tetracycline in patients with PEO, if any, and to clarify the mechanisms of action for antioxidant effects of tetracyclines in mitochondrial disorders and other diseases. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4905758</comments>
            <pubDate>Wed, 08 Jun 2011 13:59:13 +0100</pubDate>
            <guid isPermaLink="false">4905758</guid>        </item>
        <item>
            <title>The gender gap in stroke: a meta‐analysis</title>
            <link>http://www.medworm.com/index.php?rid=4905761&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01514.x</link>
            <description>Conclusions –  Gender differences have been identified on the risk factors profile and diagnostic and therapeutic management of patients with ischemic stroke. Active measures should thus be taken to avoid bias in clinical practice. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4905761</comments>
            <pubDate>Tue, 07 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4905761</guid>        </item>
        <item>
            <title>Effects of high‐dose paracetamol on blood pressure in acute stroke</title>
            <link>http://www.medworm.com/index.php?rid=4905760&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01529.x</link>
            <description>Conclusion –  High‐dose paracetamol reduces not only body temperature but also systolic blood pressure in the first 12 h after start of treatment. Both effects may improve functional outcome after stroke, but this needs further study. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4905760</comments>
            <pubDate>Tue, 07 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4905760</guid>        </item>
        <item>
            <title>Frequency and severity of headache is worsened by Interferon‐β therapy in patients with multiple sclerosis</title>
            <link>http://www.medworm.com/index.php?rid=4905759&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01532.x</link>
            <description>Conclusion –  IFNβ treatment could worsen HA in patients with pre‐existing HA or cause the appearance of new HA. Among different IFNβ preparations, Rebif® 44 and Avonex® seemed to be more cephalalgic than the other drugs. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4905759</comments>
            <pubDate>Tue, 07 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4905759</guid>        </item>
        <item>
            <title>Median nerve ultrasonography in distinguishing neuropathy sub‐types: a pilot study</title>
            <link>http://www.medworm.com/index.php?rid=4866334&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01527.x</link>
            <description>Conclusion –  This prospective, blinded, pilot study is the first to indicate the diagnostic potential of US, as performed routinely, in distinguishing between acquired demyelinating and axonal neuropathy. These findings now require confirmation in larger, adequately designed studies, evaluating other nerves/nerve sites, assessing healthy controls and taking into account interrater and equipment variabilities. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4866334</comments>
            <pubDate>Fri, 27 May 2011 14:02:50 +0100</pubDate>
            <guid isPermaLink="false">4866334</guid>        </item>
        <item>
            <title>Isolated seizures in rats do not cause neuronal injury</title>
            <link>http://www.medworm.com/index.php?rid=4866340&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01521.x</link>
            <description>Conclusion –  Our study suggests that isolated seizures cause minimal neuronal injury in rats. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4866340</comments>
            <pubDate>Wed, 25 May 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4866340</guid>        </item>
        <item>
            <title>Is there any circadian variation consequence on acute case fatality of stroke? Takashima Stroke Registry, Japan (1990–2003)</title>
            <link>http://www.medworm.com/index.php?rid=4866339&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01522.x</link>
            <description>Conclusion –  In the examination of circadian variation of stroke case fatality, 28‐day case fatality rate tended to be higher for the morning strokes. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4866339</comments>
            <pubDate>Wed, 25 May 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4866339</guid>        </item>
        <item>
            <title>Long‐term exposure to duodenal levodopa/carbidopa infusion therapy improves quality of life in relation especially to mobility, activities of daily living, and emotional well‐being</title>
            <link>http://www.medworm.com/index.php?rid=4866338&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01523.x</link>
            <description>Conclusions– DLI improves QoL in patients with advanced PD after short‐ and long‐term exposure. Whereas all domains except social support improve after 6 months under DLI, only mobility, activities of daily living and emotional well‐being improve significantly after long‐term exposure to DLI. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4866338</comments>
            <pubDate>Wed, 25 May 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4866338</guid>        </item>
        <item>
            <title>The role of IL‐15 in central nervous system disorders</title>
            <link>http://www.medworm.com/index.php?rid=4866337&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01524.x</link>
            <description>Rentzos M, Rombos A. The role of IL‐15 in central nervous system disorders. Acta Neurol Scand: DOI: 10.1111/j.1600‐0404.2011.01524.x. © 2011 John Wiley &amp; Sons A/S.IL‐15 is a proinflammatory cytokine. It is produced by activated blood monocytes, macrophages, dendritic cells, and activated glial cells. It promotes T‐cell proliferation, induction of cytolytic effector cells including natural killer and cytotoxic cells and stimulates B‐cell to proliferate and secrete immunoglobulins. Little information is available on the exact role of IL‐15 in the neurological diseases. Microglial cells are the main regulators of both innate and adaptive immune responses in the central nervous system (CNS). IL‐15 may be involved in the inflammatory reactions and microglial activation of...</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4866337</comments>
            <pubDate>Wed, 25 May 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4866337</guid>        </item>
        <item>
            <title>Galantamine and behavior in Alzheimer disease: analysis of four trials</title>
            <link>http://www.medworm.com/index.php?rid=4866336&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01525.x</link>
            <description>Conclusions –  Galantamine reduces behavioral symptoms in patients with mild to moderate AD, leading to reduced caregiver burden. The reductions were greatest in patients with moderate or advanced moderate disease. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4866336</comments>
            <pubDate>Wed, 25 May 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4866336</guid>        </item>
        <item>
            <title>Cumulative impact of comorbidity on quality of life in MS</title>
            <link>http://www.medworm.com/index.php?rid=4866335&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01526.x</link>
            <description>Conclusions – Comorbidity is associated with reduced HRQOL in MS. Further research should evaluate whether more aggressive treatment of comorbidities improves the HRQOL of MS patients. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4866335</comments>
            <pubDate>Wed, 25 May 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4866335</guid>        </item>
        <item>
            <title>Ventriculomegaly and balance disturbances in patients with TIA</title>
            <link>http://www.medworm.com/index.php?rid=4795770&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01520.x</link>
            <description>Conclusion –  Ventriculomegaly is a common finding in elderly. One out of 20 patients with TIA may suffer from INPH, existing before and independent of the TIA diagnosis. Therefore, patients presenting with ventriculomegaly and gait/balance disturbances not attributable to other causes should be referred to a hydrocephalus centre or a neurologist with special interest in INPH. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4795770</comments>
            <pubDate>Sat, 07 May 2011 21:11:30 +0100</pubDate>
            <guid isPermaLink="false">4795770</guid>        </item>
        <item>
            <title>EMMPRIN levels in serum of patients with amyotrophic lateral sclerosis</title>
            <link>http://www.medworm.com/index.php?rid=4795771&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01519.x</link>
            <description>Conclusion –  The results indicate that EMMPRIN is implicated in pathophysiology of ALS and may be the marker of clinical state severity. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4795771</comments>
            <pubDate>Fri, 06 May 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4795771</guid>        </item>
        <item>
            <title>Reply: assessment of cerebral autoregulation in human research</title>
            <link>http://www.medworm.com/index.php?rid=4711182&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2010.01471.x</link>
            <description>(Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4711182</comments>
            <pubDate>Thu, 14 Apr 2011 20:52:53 +0100</pubDate>
            <guid isPermaLink="false">4711182</guid>        </item>
        <item>
            <title>Assessment of cerebral autoregulation in human research</title>
            <link>http://www.medworm.com/index.php?rid=4711181&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2010.01470.x</link>
            <description>(Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4711181</comments>
            <pubDate>Thu, 14 Apr 2011 20:52:53 +0100</pubDate>
            <guid isPermaLink="false">4711181</guid>        </item>
        <item>
            <title>Validation of the multiple sclerosis international quality of life (MusiQoL) questionnaire in Norwegian patients</title>
            <link>http://www.medworm.com/index.php?rid=4688036&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01518.x</link>
            <description>Conclusions –  These results demonstrate that the Norwegian‐language version of the MusiQoL questionnaire is a valid and reliable instrument for assessing health‐related QoL in Norwegian patients with MS. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4688036</comments>
            <pubDate>Fri, 08 Apr 2011 18:27:42 +0100</pubDate>
            <guid isPermaLink="false">4688036</guid>        </item>
        <item>
            <title>Coping strategies as related to medical and demographic data in amyotrophic lateral sclerosis</title>
            <link>http://www.medworm.com/index.php?rid=4688038&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01513.x</link>
            <description>Discussion –  Our study clearly demonstrated the relationships between coping strategies and medical as well as demographic variables. These results encourage us to develop further investigations to better understand these relationships and to offer better adapted psychological interventions for patients with ALS. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4688038</comments>
            <pubDate>Wed, 06 Apr 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4688038</guid>        </item>
        <item>
            <title>LINGO1 variants in essential tremor and Parkinson’s disease</title>
            <link>http://www.medworm.com/index.php?rid=4688037&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01516.x</link>
            <description>Deng H, Gu S, Jankovic J. LINGO1 variants in essential tremor and Parkinson’s disease. Acta Neurol Scand: DOI: 10.1111/j.1600‐0404.2011.01516.x. © 2011 John Wiley &amp; Sons A/S.The leucine‐rich repeat and Ig domain containing 1 gene (LINGO1), recently considered to be conferred increased risk of essential tremor (ET), has been also implicated in Parkinson disease (PD). As the two common movement disorders have overlapping clinical and pathological features, it has been postulated that the LINGO1 gene may play a role in the pathogenesis of the two diseases. Here, we review published reports of the LINGO1 variants in ET and PD in an attempt to better understand the molecular and pathogenic relationship of LINGO1 to the two disorders. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4688037</comments>
            <pubDate>Wed, 06 Apr 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4688037</guid>        </item>
        <item>
            <title>Hippocampal atrophy in temporal lobe epilepsy: the ‘generator’ and ‘receiver’</title>
            <link>http://www.medworm.com/index.php?rid=4688041&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01510.x</link>
            <description>Conclusion –  The epileptogenic hippocampal atrophy has an anatomically distinct pattern compared with the contralateral hippocampus. This information may help guide the presurgical assessment of MTLE. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4688041</comments>
            <pubDate>Tue, 05 Apr 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4688041</guid>        </item>
        <item>
            <title>Dynamic cerebral autoregulation associates with infarct size and outcome after ischemic stroke</title>
            <link>http://www.medworm.com/index.php?rid=4688040&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01515.x</link>
            <description>Conclusions –  Impairment of DCA ipsilateral to acute ischemic stroke is associated with larger infarction. Dysautoregulation tends to worsen and spread to the contralateral side over the first days post‐stroke and is associated with poor clinical outcome. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4688040</comments>
            <pubDate>Tue, 05 Apr 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4688040</guid>        </item>
        <item>
            <title>Drug and treatment costs in Parkinson’s disease patients in Sweden</title>
            <link>http://www.medworm.com/index.php?rid=4688039&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01517.x</link>
            <description>Conclusion –  Our study estimates high direct costs in patients with PD in Sweden, SEK 1.7 billion, 52% for inpatient care, 27% for outpatient care and 21% for drugs. With an ageing population and the medical progress, the financial burden on society will most probably increase in the future. This study might initiate and provide information for discussions about future cost allocations and healthcare priorities. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4688039</comments>
            <pubDate>Tue, 05 Apr 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4688039</guid>        </item>
        <item>
            <title>Major depression and bipolar disorders in CADASIL: a study using the DSM‐IV semi‐structured interview</title>
            <link>http://www.medworm.com/index.php?rid=4628273&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01512.x</link>
            <description>Conclusion –  This study confirms that mood disorders are frequent in CADASIL. The use of a structured psychiatric interview outlines a frequency of depression higher than that previously reported but also reveals a considerable frequency of bipolar disorders. If confirmed in larger series, these data suggest that a greater attention should be paid to the psychiatric aspects in CADASIL. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4628273</comments>
            <pubDate>Thu, 24 Mar 2011 18:40:03 +0100</pubDate>
            <guid isPermaLink="false">4628273</guid>        </item>
        <item>
            <title>Clinical characteristics of Guillain–Barré syndrome in a tropical country: a Brazilian experience</title>
            <link>http://www.medworm.com/index.php?rid=4628276&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01503.x</link>
            <description>Conclusion –  A predominance of the AIDP variant was seen, and the incidence of the disease decreased with age. As expected, the distribution of weakness correlated with the clinical variants, and individuals with the axonal variant had a poorer prognosis. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4628276</comments>
            <pubDate>Thu, 24 Mar 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4628276</guid>        </item>
        <item>
            <title>Altered cerebrospinal fluid index of prealbumin, fibrinogen, and haptoglobin in patients with Guillain–Barré syndrome and chronic inflammatory demyelinating polyneuropathy</title>
            <link>http://www.medworm.com/index.php?rid=4628275&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01511.x</link>
            <description>Conclusions –  Our data provide preliminary evidence that GBS is associated with low CSF index levels of prealbumin and fibrinogen, but normal levels of haptoglobin, whereas CIDP is associated with normal CSF index levels of prealbumin, low fibrinogen, and high levels of haptoglobin. Further studies are needed to identify the underlying mechanisms behind these CSF protein alterations and to clarify whether prealbumin, fibrinogen, and haptoglobin can serve as useful biomarkers for GBS and CIDP. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4628275</comments>
            <pubDate>Thu, 24 Mar 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4628275</guid>        </item>
        <item>
            <title>Gastric and small intestinal dysfunction in spinal cord injury patients</title>
            <link>http://www.medworm.com/index.php?rid=4628274&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01508.x</link>
            <description>Conclusion –  Surprisingly, upper gastrointestinal transit is prolonged in subjects with SCI suffering from bowel problems, not only in subjects with cervical or high thoracic lesions but also in subjects with conal/cauda equina lesions. We speculate that this is secondary to colonic dysfunction and constipation. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4628274</comments>
            <pubDate>Thu, 24 Mar 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4628274</guid>        </item>
        <item>
            <title>Irritable bowel syndrome associated with mitral valve prolapse and autonomic and haemostatic abnormalities in children, adolescents and adults with migraine</title>
            <link>http://www.medworm.com/index.php?rid=4623771&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2010.01456.x</link>
            <description>(Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4623771</comments>
            <pubDate>Wed, 23 Mar 2011 18:44:25 +0100</pubDate>
            <guid isPermaLink="false">4623771</guid>        </item>
        <item>
            <title>Adjunctive pregabalin for uncontrolled partial‐onset seizures: findings from a prospective audit</title>
            <link>http://www.medworm.com/index.php?rid=4617756&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01507.x</link>
            <description>Conclusions –  Add‐on PGB benefited 50% of patients, but only 10% achieved 6 months’ seizure freedom. Adverse effects, most commonly sedation, dose‐related weight gain and ataxia, led to drug discontinuation by 45%. Prospective audits of novel AEDs are a useful adjunct to randomized, controlled trials in managing epilepsy. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4617756</comments>
            <pubDate>Tue, 22 Mar 2011 18:58:20 +0100</pubDate>
            <guid isPermaLink="false">4617756</guid>        </item>
        <item>
            <title>SCA14 in Norway, two families with autosomal dominant cerebellar ataxia and a novel mutation in the PRKCG gene</title>
            <link>http://www.medworm.com/index.php?rid=4617758&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01504.x</link>
            <description>Conclusions –  These are the first families with SCA14 reported from Scandinavia and a new mutation in the PRKCG gene. The occurrence in the Norwegian dominant ataxia cohort is 3.5%. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4617758</comments>
            <pubDate>Mon, 21 Mar 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4617758</guid>        </item>
        <item>
            <title>Epilepsy: fractures and the role of cumulative antiepileptic drug load</title>
            <link>http://www.medworm.com/index.php?rid=4617757&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01509.x</link>
            <description>Conclusion – In this high‐risk population, we obtained a positive and strong correlation between the occurrence of fractures in a diagnosed population with osteoporosis and the cumulative drug load of AEDs. This effect seems general, independent of the type of AEDs that were used. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4617757</comments>
            <pubDate>Mon, 21 Mar 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4617757</guid>        </item>
        <item>
            <title>Obstructive sleep apnea in children with epilepsy: prospective pilot trial</title>
            <link>http://www.medworm.com/index.php?rid=4607385&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01506.x</link>
            <description>Conclusions –  OSA is more prevalent in refractory epilepsy and in children who are on multiple AEDs. While further studies are needed to confirm these findings and to assess the consequences of OSA, we believe it is important to screen the children with epilepsy for OSA. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4607385</comments>
            <pubDate>Thu, 17 Mar 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4607385</guid>        </item>
        <item>
            <title>Interleukin 6–174G&gt;C polymorphism and risk of aneurysmal subarachnoid hemorrhage: case–control study and meta‐analysis</title>
            <link>http://www.medworm.com/index.php?rid=4597003&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01505.x</link>
            <description>Conclusions –  We failed to find an association between the IL6 ‐174G&amp;gt;C polymorphism and aSAH in analyzed European populations. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4597003</comments>
            <pubDate>Wed, 16 Mar 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4597003</guid>        </item>
        <item>
            <title>Validation of the Swedish inpatient and cause‐of‐death registers in the context of stroke</title>
            <link>http://www.medworm.com/index.php?rid=4533608&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2010.01402.x</link>
            <description>Conclusions –  Quality follow‐up within stroke care could be biased or have low comparability, when administrative data are used. Great caution should be taken when data derived from the inpatient and cause‐of‐death registers, and more validation work needs to be carried out in the context of stroke. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4533608</comments>
            <pubDate>Tue, 01 Mar 2011 22:51:49 +0100</pubDate>
            <guid isPermaLink="false">4533608</guid>        </item>
        <item>
            <title>Intravenous sodium valproate aborts migraine headaches rapidly</title>
            <link>http://www.medworm.com/index.php?rid=4533607&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2010.01394.x</link>
            <description>Conclusions –  Intravenous Sodium Valproate (iVPA) seems to be safe and rapidly effective for intractable migraine attack. Randomized, double‐blinded, controlled studies are warranted. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4533607</comments>
            <pubDate>Tue, 01 Mar 2011 22:51:42 +0100</pubDate>
            <guid isPermaLink="false">4533607</guid>        </item>
        <item>
            <title>Predictive value of motor evoked potentials in clinically isolated syndrome</title>
            <link>http://www.medworm.com/index.php?rid=4533606&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01498.x</link>
            <description>Conclusions –  Contralateral silent period (SP) seems to be a valuable parameter to early distinguish patients who will develop MS or not. This result about SP during CIS has never been described until now. An increased contralateral silent period would predict a conversion to MS with a positive predictive value of 75%, but this result needs to be confirmed in larger groups. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4533606</comments>
            <pubDate>Tue, 01 Mar 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4533606</guid>        </item>
        <item>
            <title>Ten‐year risk for myocardial infarction in patients with first‐ever stroke: a community‐based study</title>
            <link>http://www.medworm.com/index.php?rid=4533605&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01500.x</link>
            <description>Conclusion –  The risk for MI is significantly higher, for both male and female stroke patients, compared to the general population. Stroke patients with previous CHD and peripheral artery disease are at highest risk. Stroke patients should receive adequate secondary prevention, and cardiac complaints must be taken seriously. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4533605</comments>
            <pubDate>Tue, 01 Mar 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4533605</guid>        </item>
        <item>
            <title>The prevalence and demographic distribution of treated epilepsy: a community‐based study in Tasmania, Australia</title>
            <link>http://www.medworm.com/index.php?rid=4533604&amp;cid=s_32218_25_f&amp;fid=32218&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1600-0404.2011.01499.x</link>
            <description>Conclusions–  Although our estimates are likely to be affected by access to health services, overall treated epilepsy prevalence of 4.4 per 1000 is similar to previous studies. Our finding of high elderly prevalence has been reported in a few recent studies in developed countries and has important clinical and public health implications in populations with similar aging demographics. (Source: Acta Neurologica Scandinavica)</description>
            <author>Acta Neurologica Scandinavica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4533604</comments>
            <pubDate>Tue, 01 Mar 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4533604</guid>        </item>
    </channel>
</rss>

